CANCER HORMONE THERAPY;
CONFERENCE PAPER;
CONFORMATIONAL TRANSITION;
CONTRACEPTION;
DRUG DNA INTERACTION;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG RECEPTOR BINDING;
FEMALE;
HORMONAL REGULATION;
HUMAN;
MEDICOLEGAL ASPECT;
PROTEIN CONFORMATION;
RECEPTOR AFFINITY;
UTERUS MYOMA;
ABORTION, DRUG INDUCED;
ANIMAL;
BIOLOGY;
BREAST TUMOR;
CANCER;
CHEMISTRY;
CONTRACEPTIVE MODE OF ACTION;
DISEASES;
DRUG ANTAGONISM;
DRUG EFFECT;
ENDOCRINE SYSTEM;
FAMILY PLANNING;
FERTILITY;
FERTILITY CONTROL, POSTCOITAL;
FERTILITY CONTROL, POSTCONCEPTION;
INDUCED ABORTION;
LITERATURE REVIEW;
METABOLISM;
NEOPLASM;
PHYSIOLOGY;
PREGNANCY;
REVIEW;
RU-486;
TREATMENT;
ABORTIFACIENT AGENTS;
ABORTION, DRUG INDUCED;
ABORTION, INDUCED;
BIOLOGY;
CANCER;
CONTRACEPTION;
CONTRACEPTIVE MODE OF ACTION;
DISEASES;
ENDOCRINE SYSTEM;
FAMILY PLANNING;
FERTILITY CONTROL, POSTCOITAL;
FERTILITY CONTROL, POSTCONCEPTION;
HORMONE ANTAGONISTS;
HORMONES;
LITERATURE REVIEW;
NEOPLASMS;
PHYSIOLOGY;
RU-486;
TREATMENT;
Switching agonistic, antagonistic, and mixed transcriptional responses to 11β-substituted progestins by mutation of the progesterone receptor
GARCIA, T., B. BENHAMOU, D. GOFFLO, et al. 1992. Switching agonistic, antagonistic, and mixed transcriptional responses to 11β-substituted progestins by mutation of the progesterone receptor. Mol. Endocrinol. 6: 2071-2078.
From RU38486 towards dissociated antiglucocorticosteroid and antiprogesterone
M. K. Agarwal, Ed.: Karger. Basel
PHILIBERT, D., G. COSTEROUSSE, M. GAILLARD-MOGUILEWSKY, et al. 1991. From RU38486 towards dissociated antiglucocorticosteroid and antiprogesterone. In Antihormones in Health and Disease. M. K. Agarwal, Ed.: 1-17, 19. Karger. Basel.
Inhibition par l'immunosuppresseur FK506 de l'effet antiglucocorticostéroïde du RU 486 sur la croissance de fibroblastes de souris en culture
JUNG-TESTAS, I., B. DELESPIERRE & E. E. BAULIEU. 1993. Inhibition par l'immunosuppresseur FK506 de l'effet antiglucocorticostéroïde du RU 486 sur la croissance de fibroblastes de souris en culture. C. R. Acad. Sci. Paris 316: 1495-1499.
Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone
GRUNBERG, S. M., M. H. WEISS, I. M. SPITZ, et al. 1991. Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. J. Neurosurg. 74:861-866.
Regression of uterine leiomyomata to the antiprogesterone RU 486: Dose-response effect
MURPHY, A. A., L. M. KETTEL, A. J. MORALÈS, et al. 1993. Regression of uterine leiomyomata to the antiprogesterone RU 486: Dose-response effect. Fertil. Steril. 64: 187-190.
The effects of an antiprogesterone steroid in women: Interruption of the menstrual cycle and of early pregnancy
HERRMANN, W., R. WYSS, A. RIONDEL, D. PHILIBERT, G. TEUTSCH, E. SAKIZ & E. E. BAULIEU. 1982. The effects of an antiprogesterone steroid in women: Interruption of the menstrual cycle and of early pregnancy. C. R. Acad. Sci. Paris 294: 933-938.
Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol
PEYRON, R., E. AUBENY, V. TARGOSZ, L. SILVESTRE, M. RENAULT, F. ELKIK, P. LECLERC, A. ULMANN & E. E. BAULIEU. 1993. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N. Engl. J. Med. 328: 1509-1513.
Institute of Medicine. National Academy Press. Washington, DC
DONALDSON, M. S., L. DORFLINGER, S. S. BROWN & L. Z. BENET, EDS. 1993. Clinical Applications of Mifepristone (RU 486) and Other Antiprogestins. Institute of Medicine. National Academy Press. Washington, DC.